Last reviewed · How we verify
PA21 with food and Losartan 2 hours later
PA21 with food and Losartan 2 hours later is a Small molecule drug developed by Vifor Pharma. It is currently in Phase 1 development.
At a glance
| Generic name | PA21 with food and Losartan 2 hours later |
|---|---|
| Sponsor | Vifor Pharma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PA21 with food and Losartan 2 hours later CI brief — competitive landscape report
- PA21 with food and Losartan 2 hours later updates RSS · CI watch RSS
- Vifor Pharma portfolio CI
Frequently asked questions about PA21 with food and Losartan 2 hours later
What is PA21 with food and Losartan 2 hours later?
PA21 with food and Losartan 2 hours later is a Small molecule drug developed by Vifor Pharma.
Who makes PA21 with food and Losartan 2 hours later?
PA21 with food and Losartan 2 hours later is developed by Vifor Pharma (see full Vifor Pharma pipeline at /company/vifor-pharma).
What development phase is PA21 with food and Losartan 2 hours later in?
PA21 with food and Losartan 2 hours later is in Phase 1.